Sanofi pours €1.3B into new insulin manufacturing plant in Frankfurt
Sanofi is investing €1.3 billion into a new insulin production facility in Germany to help with long-term supply and add power to its European supply …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.